Circul8 Pro β
Portable compression device offered through PMP for DVT prevention. [16][18]
FDA-clearedCommercially offered; exact model and country availability should be confirmed with the manufacturer.

Branded DVT-prevention and recovery products supported by patient delivery and service operations.
Precision Medical Products offers prevention and recovery products, including Circul8 Pro portable compression for DVT prevention. Its operating model includes product delivery, patient support and durable-medical-equipment services alongside its branded portfolio.
The matched FDA Circul8 Pro and Circul8 Luxe decisions name Ortho8, Inc. as applicant. The profile retains that legal applicant rather than attributing those clearances directly to PMP. An older Circul8 Luxe recall remains open in the reviewed FDA record; its later clearance does not itself terminate the recall.
This profile covers PMPβs own branded prevention and recovery offering. Current headquarters and chief-executive identity require further reconciliation: company material includes a California address and an earlier Texas relocation announcement, so neither is presented as settled current headquarters.
Circul8 Proβs authorizations and current commercial role are distinct from the legacy Circul8 Luxe/EVEXIA Luxe recall. Other Ortho8 products and similarly named needle manufacturers are not automatically part of the current Precision portfolio. [14][16][2][3][1]
The matched FDA history contains 1 distinct recall event: 1 open, 0 terminated. Z-2324-2021 (2021-07-09; open, classified): CIRCUL8 LUXE DVT PREVENTION DEVICE is marketed without FDA clearance [10][11]
Latest recorded source review: 2026-10-20.
Includes open events outside the mapped current portfolio; those events are excluded from the snapshot count.
Documented commercial product families.
Portable compression device offered through PMP for DVT prevention. [16][18]
FDA-clearedCommercially offered; exact model and country availability should be confirmed with the manufacturer.
Legacy model retained to show the matched authorization and historical recall. [14][17]
Commercial availability not establishedCurrent availability not established.
Current Pro offering separated from legacy Luxe regulatory history. Headquarters and current CEO remain unresolved. [14][16]
Accessed 10/20/2026